166 related articles for article (PubMed ID: 37358683)
1. Breast-Conserving Therapy is Associated with Improved Survival Without an Increased Risk of Locoregional Recurrence Compared with Mastectomy in Both Clinically Node-Positive and Node-Negative Breast Cancer Patients.
Vasilyeva E; Hamm J; Nichol A; Isaac KV; Bazzarelli A; Brown C; Lohrisch C; McKevitt E
Ann Surg Oncol; 2023 Oct; 30(11):6413-6424. PubMed ID: 37358683
[TBL] [Abstract][Full Text] [Related]
2. Locoregional recurrence and survival outcomes by type of local therapy and trastuzumab use among women with node-negative, HER2-positive breast cancer.
Peterson DJ; Truong PT; Sadek BT; Alexander CS; Wiksyk B; Shenouda M; Raad RA; Taghian AG
Ann Surg Oncol; 2014 Oct; 21(11):3490-6. PubMed ID: 24841346
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Survival After Breast-Conserving Therapy vs Mastectomy Among Patients With or Without the BRCA1/2 Variant in a Large Series of Unselected Chinese Patients With Breast Cancer.
Wan Q; Su L; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
JAMA Netw Open; 2021 Apr; 4(4):e216259. PubMed ID: 33890992
[TBL] [Abstract][Full Text] [Related]
4. Breast conserving therapy is associated with improved overall survival compared to mastectomy in early-stage, lymph node-negative breast cancer.
Almahariq MF; Quinn TJ; Siddiqui Z; Jawad MS; Chen PY; Gustafson GS; Dilworth JT
Radiother Oncol; 2020 Jan; 142():186-194. PubMed ID: 31615634
[TBL] [Abstract][Full Text] [Related]
5. Omitting radiation therapy in women with triple-negative breast cancer leads to worse breast cancer-specific survival.
Kindts I; Buelens P; Laenen A; Van Limbergen E; Janssen H; Wildiers H; Weltens C
Breast; 2017 Apr; 32():18-25. PubMed ID: 28012411
[TBL] [Abstract][Full Text] [Related]
6. Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy.
Abdulkarim BS; Cuartero J; Hanson J; Deschênes J; Lesniak D; Sabri S
J Clin Oncol; 2011 Jul; 29(21):2852-8. PubMed ID: 21670451
[TBL] [Abstract][Full Text] [Related]
7. Triple-negative breast cancer is not a contraindication for breast conservation.
Adkins FC; Gonzalez-Angulo AM; Lei X; Hernandez-Aya LF; Mittendorf EA; Litton JK; Wagner J; Hunt KK; Woodward WA; Meric-Bernstam F
Ann Surg Oncol; 2011 Oct; 18(11):3164-73. PubMed ID: 21947595
[TBL] [Abstract][Full Text] [Related]
8. T1-2N0M0 Triple-Negative Breast Cancer Treated With Breast-Conserving Therapy Has Better Survival Compared to Mastectomy: A SEER Population-Based Retrospective Analysis.
Li H; Chen Y; Wang X; Tang L; Guan X
Clin Breast Cancer; 2019 Dec; 19(6):e669-e682. PubMed ID: 31375327
[TBL] [Abstract][Full Text] [Related]
9. Breast-conserving surgery is an appropriate procedure for centrally located breast cancer: a population-based retrospective cohort study.
Yuan YW; Liu PC; Li FF; Yang YH; Yang W; Fan L; Mou DW; Yang HW; Chen MS
BMC Surg; 2023 Oct; 23(1):298. PubMed ID: 37789365
[TBL] [Abstract][Full Text] [Related]
10. Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer.
Woodward WA; Barlow WE; Jagsi R; Buchholz TA; Shak S; Baehner F; Whelan TJ; Davidson NE; Ingle JN; King TA; Ravdin PM; Osborne CK; Tripathy D; Livingston RB; Gralow JR; Hortobagyi GN; Hayes DF; Albain KS
JAMA Oncol; 2020 Apr; 6(4):505-511. PubMed ID: 31917424
[TBL] [Abstract][Full Text] [Related]
11. Early-stage young breast cancer patients: impact of local treatment on survival.
Bantema-Joppe EJ; de Munck L; Visser O; Willemse PH; Langendijk JA; Siesling S; Maduro JH
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e553-9. PubMed ID: 21601378
[TBL] [Abstract][Full Text] [Related]
12. Survival outcomes after breast-conserving therapy compared with mastectomy for patients with early-stage metaplastic breast cancer: a population-based study of 2412 patients.
Zhang J; Yang C; Lei C; Zhang Y; Ji F; Gao H; Yang M; Zhang L; Li J; Zhu T; Li W; Zhuang X; Wang K
Breast; 2021 Aug; 58():10-17. PubMed ID: 33878598
[TBL] [Abstract][Full Text] [Related]
13. Impact of local surgical treatment on survival in young women with T1 breast cancer: long-term results of a population-based cohort.
Jeon YW; Choi JE; Park HK; Kim KS; Lee JY; Suh YJ
Breast Cancer Res Treat; 2013 Apr; 138(2):475-84. PubMed ID: 23456232
[TBL] [Abstract][Full Text] [Related]
14. Impact of Locoregional Treatment on Survival in Young Patients with Early-Stage Breast Cancer undergoing Upfront Surgery.
Orozco JIJ; Keller JK; Chang SC; Fancher CE; Grumley JG
Ann Surg Oncol; 2022 Oct; 29(10):6299-6310. PubMed ID: 35896922
[TBL] [Abstract][Full Text] [Related]
15. Ten-year recurrence rates in young women with breast cancer by locoregional treatment approach.
Beadle BM; Woodward WA; Tucker SL; Outlaw ED; Allen PK; Oh JL; Strom EA; Perkins GH; Tereffe W; Yu TK; Meric-Bernstam F; Litton JK; Buchholz TA
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):734-44. PubMed ID: 18707822
[TBL] [Abstract][Full Text] [Related]
16. Loco-regional control after neo-adjuvant chemotherapy and conservative treatment for locally advanced breast cancer patients.
Levy A; Borget I; Bahri M; Arnedos M; Rivin E; Vielh P; Balleyguier C; Rimareix F; Bourgier C
Breast J; 2014; 20(4):381-7. PubMed ID: 24890310
[TBL] [Abstract][Full Text] [Related]
17. Breast-conserving therapy is associated with better survival than mastectomy in Early-stage breast cancer: A propensity score analysis.
Ji J; Yuan S; He J; Liu H; Yang L; He X
Cancer Med; 2022 Apr; 11(7):1646-1658. PubMed ID: 35212160
[TBL] [Abstract][Full Text] [Related]
18. Breast surgery for young women with early-stage breast cancer: Mastectomy or breast-conserving therapy?
Sun ZH; Chen C; Kuang XW; Song JL; Sun SR; Wang WX
Medicine (Baltimore); 2021 May; 100(18):e25880. PubMed ID: 33951002
[TBL] [Abstract][Full Text] [Related]
19. Effects of Breast-Conserving Surgery and Mastectomy on the Survival of Patients with Early-Stage (T1-2N0-1M0) HER2-Positive Breast Cancer: A Propensity Score-Matched Analysis.
Zhan Q; Zhao X; Zheng G; Liu J; Wu S; Huang J; Yu L; Fu F
Oncol Res Treat; 2023; 46(12):511-519. PubMed ID: 37931609
[TBL] [Abstract][Full Text] [Related]
20. Ten-year locoregional recurrence risks in women with nodal micrometastatic breast cancer staged with axillary dissection.
Lupe K; Truong PT; Alexander C; Speers C; Tyldesley S
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e681-8. PubMed ID: 21300456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
